Special Issue "Attitudes and Perspectives toward COVID-19 Vaccines"
Deadline for manuscript submissions: 31 December 2023 | Viewed by 7727
Interests: legal medicine; informed consent; risk management; health responsibility; forensic pathology
Interests: prevention public health; epidemiology; vaccinations; AEFI surveillance
Interests: respiratory disease of the newborn; non-invasive ventilation; HFT; neonatal and pediatric nutrition; vaccination; neonatal and pediatric COVID-19; neonatal infections; genetic and rare neonatal diseases; congenital malformations; informed consent for minors; infectious disease transmissions; off labelel
Special Issues, Collections and Topics in MDPI journals
Vaccination hesitancy has been a major issue since the first vaccine’s introduction. The very idea of “delivering treatment” to a healthy person is alien to our mindset, eliciting suspicion among those who lack proper education. COVID-19 vaccines have been developed over a surprisingly short period, and this further aggravated the public’s opinion regarding immunization practices.
Although some anti-vaccination groups still state that vaccines are not effective in preventing infectious diseases, the last two years’ debate has been polarized towards vaccination safety. Most concerns regarding COVID-19 vaccination are indeed focused on the risk of adverse events following the administration of products with, supposedly, too fast a development to ensure their own reliability. However, both pre- and post-marketing evidence suggest that available anti-COVID-19 vaccines are safe for use in humans, with little risk of serious adverse events. Given this scenario, communication appears as the main tool to prevent and counteract vaccination hesitancy.
This Research Topic will focus on the phenomenon of VH in the general population and its subgroups and aims to cover the main determinants of vaccine attitude and the strategies to deal with VH in some high-risk subgroups of the population (healthcare workers, parents and pregnancy woman).
Dr. Maricla Marrone
Prof. Dr. Pasquale Stefanizzi
Prof. Dr. Nicola Laforgia
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- legal medicine
- informed consent
- risk management
- health responsibility
- prevention public health
- contact tracking